Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates

Journal of Heart and Lung Transplantation

Volumn 24, Issue 6, 2005, Pages 690-695

  Radovancevic, Branislav ^a,b   Vrtovec, Bojan ^a   Thomas, Cynthia D ^a   Croitoru, Mihai ^a   Myers, Timothy J ^a   Radovancevic, Rajko ^a   Khan, Tehreen ^a   Massin, Edward K ^a   Frazier, O H ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN E1;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART FAILURE; HEART GRAFT; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, INHALATION; ADULT; ALPROSTADIL; CROSS-OVER STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NITRIC OXIDE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 20444416715     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.04.016     Document Type: Article

References (22)

1. K. Chatterjee, T. De Marco, J.S. Alpert Pulmonary hypertension hemodynamic diagnosis and management Arch Intern Med 162 2002 1925 1933
2. L.J. Addonizio, W.M. Gersony, R.C. Robbins Elevated pulmonary vascular resistance and cardiac transplantation Circulation 76 1987 V52 V55
3. J.M. Chen, H.R. Levin, R.E. Michler Reevaluating the significance of pulmonary hypertension before cardiac transplantation determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality J Thorac Cardiovasc Surg 114 1997 627 634
4. G. Tenderich, M.M. Koerner, B. Stuettgen Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient >15 mm Hg or >5 wood) predict early and long-term results after orthotopic heart transplantation? Transplant Proc 30 1998 1130 1131
5. E.M. Chau, K.R. Bailey, D.W. Mahoney Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year Circulation 94 suppl 9 1996 II267 II272
6. C. Espinoza, N. Manito, J. Roca Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation importance in the postoperative morbidity and mortality Transplant Proc 31 1999 2503 2504
7. S. Murali, B.F. Uretsky, P.S. Reddy Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation comparative effects of various pharmacologic agents Am Heart J 122 1991 1375 1381
8. F. Iberer, A. Wasler, K. Tscheliessnigg Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance Survival on waiting list and results of orthotopic heart transplantation J Heart Lung Transplant 12 1993 173 178
9. R. Pacher, B. Stanek, M. Hulsmann Effect of prostaglandin E1 infusion in severe chronic heart failure Prostaglandins 53 1997 221 235
10. S. Murali, B.F. Uretsky, J.M. Armitage Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension J Heart Lung Transplant 11 1992 716 723
11. W. Steudel, W.E. Hurford, W.M. Zapol Inhaled nitric oxide basic biology and clinical applications Anesthesiology 91 1999 1090 1121
12. M.J. Semigran, B.A. Cockrill, R. Kacmarek Hemodynamic effects of inhaled nitric oxide in heart failure J Am Coll Cardiol 24 1994 982 988
13. R. Pacher, B. Stanek, M. Hulsmann Prostaglandin E1 - bridge to cardiac transplantation. Technique, dosage, results Eur Heart J 18 1997 318 329
14. F. Iberer, A. Wasler, B. Petutschnigg Prostaglandins in heart transplantation Adv Exp Med Biol 433 1997 19 22
15. E. Barbieri, P. Perini, P. Marino Combined hemodynamic echocardiographic Doppler evaluation of prostaglandin E1 effects in patients with severe dilated cardiomyopathy undergoing evaluation for heart transplantation J Heart Lung Transplant 14 1995 572 578
16. R. Pacher, S. Globits, M. Wutte Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure results of a prospective, randomized, controlled study Crit Care Med 22 1994 1084 1090
17. L.J. McDonald, F. Murad Nitric oxide and cGMP signaling Adv Pharmacol 34 1995 263 275
18. S. Rimar, C.N. Gillis Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation Circulation 88 1993 2884 2887
19. A.P. Goldman, R.E. Delius, J.E. Deanfield Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations Ann Thorac Surg 60 1995 300 305
20. A. Ardehali, K. Hughes, A. Sadeghi Inhaled nitric oxide for pulmonary hypertension after heart transplantation Transplantation 72 2001 638 641
21. I. Mosquera, M.G. Crespo-Leiro, T. Tabuyo Pulmonary hypertension and right ventricular failure after heart transplantation usefulness of nitric oxide Transplant Proc 34 2002 166 167
22. P. Krieg, T. Wahlers, W. Giess Inhaled nitric oxide and inhaled prostaglandin E1 effect on left ventricular contractility when used for treatment of experimental pulmonary hypertension Eur J Cardiothorac Surg 14 1998 494 502